Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Claudia
Contact Claudia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Baseline Cognitive and Neurological Status Does Not Modify the Occurrence of ICANS in CAR T‐Cell Therapy for Aggressive B‐Cell Lymphoma
1 Introduction Chimeric antigen receptor (CAR) T-cell therapy has dramatically modified the landscape of cancer treatment, particularly in haematological malignancies [1, 2]. Although its efficacy in inducing durable remissions is undeniable, the occurrence of neurotoxicity is a major challenge as it induces acute morbidity, potentially requiring ICU transfer and prolonged hospitalisation [3, 4].
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Claudia
Contact Claudia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack